| acetylcholine transport | GO:0015870 | 2 | 0.728 | |
| synaptic transmission | GO:0007268 | 329 | 0.411 | |
| acetate ester transport | GO:1901374 | 2 | 0.324 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.149 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.149 | |
| pigment accumulation | GO:0043476 | 1 | 0.147 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.143 | |
| anterograde axon cargo transport | GO:0008089 | 20 | 0.125 | |
| muscle cell development | GO:0055001 | 133 | 0.102 | |
| microtubule based movement | GO:0007018 | 84 | 0.101 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.095 | |
| pigmentation | GO:0043473 | 71 | 0.091 | |
| cellular homeostasis | GO:0019725 | 240 | 0.090 | |
| transmembrane transport | GO:0055085 | 412 | 0.089 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.087 | |
| cation transport | GO:0006812 | 399 | 0.081 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.080 | |
| synaptic transmission cholinergic | GO:0007271 | 7 | 0.079 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.079 | |
| wound healing | GO:0042060 | 157 | 0.078 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.073 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.072 | |
| vesicle organization | GO:0016050 | 60 | 0.070 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.065 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.064 | |
| amine metabolic process | GO:0009308 | 45 | 0.063 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.060 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.059 | |
| coagulation | GO:0050817 | 78 | 0.059 | |
| locomotory behavior | GO:0007626 | 195 | 0.058 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.058 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.058 | |
| melanosome organization | GO:0032438 | 8 | 0.055 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.052 | |
| dephosphorylation | GO:0016311 | 129 | 0.052 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.052 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.051 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.049 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.048 | |
| sarcomere organization | GO:0045214 | 24 | 0.048 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.046 | |
| neuronal action potential | GO:0019228 | 54 | 0.045 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.044 | |
| organelle assembly | GO:0070925 | 177 | 0.043 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.042 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.041 | |
| regulation of natural killer cell activation | GO:0032814 | 22 | 0.040 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.038 | |
| hemostasis | GO:0007599 | 78 | 0.037 | |
| mitochondrion organization | GO:0007005 | 134 | 0.035 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.035 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.034 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.033 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.033 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.033 | |
| anterograde synaptic vesicle transport | GO:0048490 | 15 | 0.033 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.033 | |
| oxidation reduction process | GO:0055114 | 342 | 0.033 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.033 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.033 | |
| microtubule based process | GO:0007017 | 236 | 0.032 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.032 | |
| myofibril assembly | GO:0030239 | 34 | 0.032 | |
| blood coagulation | GO:0007596 | 76 | 0.032 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.031 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.031 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.031 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.029 | |
| establishment of melanosome localization | GO:0032401 | 11 | 0.029 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.029 | |
| membrane organization | GO:0061024 | 245 | 0.029 | |
| muscle cell cellular homeostasis | GO:0046716 | 12 | 0.029 | |
| cell adhesion | GO:0007155 | 329 | 0.028 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.028 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.027 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.027 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.027 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.027 | |
| organelle localization | GO:0051640 | 179 | 0.027 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.026 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.026 | |
| camera type eye development | GO:0043010 | 266 | 0.026 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.026 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.026 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.026 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.026 | |
| microtubule based transport | GO:0010970 | 50 | 0.025 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.025 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.025 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.025 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.025 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.024 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.024 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.024 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.023 | |
| intracellular protein transport | GO:0006886 | 204 | 0.023 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.023 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.022 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.022 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.022 | |
| pigment granule localization | GO:0051875 | 13 | 0.022 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.021 | |
| regulation of cell activation | GO:0050865 | 289 | 0.021 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.021 | |
| vesicle localization | GO:0051648 | 86 | 0.021 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.020 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.020 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.020 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.020 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.020 | |
| protein targeting | GO:0006605 | 143 | 0.020 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.020 | |
| chemotaxis | GO:0006935 | 247 | 0.019 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.019 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.019 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.019 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.019 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.019 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.019 | |
| melanocyte differentiation | GO:0030318 | 25 | 0.019 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.019 | |
| protein catabolic process | GO:0030163 | 221 | 0.019 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.019 | |
| endocytosis | GO:0006897 | 168 | 0.019 | |
| cellular pigmentation | GO:0033059 | 20 | 0.019 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.018 | |
| neuromuscular process | GO:0050905 | 99 | 0.018 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.018 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.018 | |
| muscle system process | GO:0003012 | 141 | 0.018 | |
| protein localization to organelle | GO:0033365 | 185 | 0.018 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.018 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.018 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.018 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.018 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.018 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.018 | |
| response to inorganic substance | GO:0010035 | 96 | 0.018 | |
| muscle tissue development | GO:0060537 | 308 | 0.018 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.018 | |
| t cell differentiation | GO:0030217 | 174 | 0.018 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.018 | |
| regulation of protein localization | GO:0032880 | 231 | 0.018 | |
| cellular response to arsenic containing substance | GO:0071243 | 4 | 0.018 | |
| pigment cell differentiation | GO:0050931 | 27 | 0.018 | |
| myelination | GO:0042552 | 74 | 0.018 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.017 | |
| t cell activation | GO:0042110 | 289 | 0.017 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.017 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.017 | |
| melanosome transport | GO:0032402 | 11 | 0.017 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.017 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.017 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.017 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.017 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.016 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.016 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.016 | |
| regulation of cell migration | GO:0030334 | 219 | 0.016 | |
| defense response to bacterium | GO:0042742 | 119 | 0.016 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.016 | |
| spermatogenesis | GO:0007283 | 284 | 0.016 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.016 | |
| protein maturation | GO:0051604 | 176 | 0.016 | |
| cytokine production | GO:0001816 | 319 | 0.016 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.016 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.015 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.015 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.015 | |
| protein targeting to vacuole | GO:0006623 | 3 | 0.015 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.015 | |
| regulation of phosphoprotein phosphatase activity | GO:0043666 | 3 | 0.015 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.015 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.015 | |
| lipid localization | GO:0010876 | 126 | 0.015 | |
| pigment granule transport | GO:0051904 | 12 | 0.015 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.015 | |
| epithelial cell development | GO:0002064 | 159 | 0.014 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.014 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.014 | |
| developmental pigmentation | GO:0048066 | 40 | 0.014 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.014 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.014 | |
| response to oxidative stress | GO:0006979 | 123 | 0.014 | |
| lipid catabolic process | GO:0016042 | 69 | 0.014 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.014 | |
| regulation of cell motility | GO:2000145 | 236 | 0.014 | |
| protein processing | GO:0016485 | 163 | 0.014 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.014 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.014 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.014 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.013 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.013 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.013 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.013 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.013 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.013 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.013 | |
| axon cargo transport | GO:0008088 | 33 | 0.013 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.013 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.013 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.013 | |
| male gamete generation | GO:0048232 | 285 | 0.013 | |
| axonogenesis | GO:0007409 | 274 | 0.013 | |
| regulation of skeletal muscle adaptation | GO:0014733 | 12 | 0.013 | |
| chromatin modification | GO:0016568 | 187 | 0.013 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.013 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.013 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.013 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.013 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.013 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.013 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.013 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.013 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.013 | |
| mapk cascade | GO:0000165 | 281 | 0.012 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.012 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.012 | |
| eye pigmentation | GO:0048069 | 3 | 0.012 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.012 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.012 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.012 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.012 | |
| gtp catabolic process | GO:0006184 | 143 | 0.012 | |
| ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway | GO:0043162 | 3 | 0.012 | |
| action potential | GO:0001508 | 78 | 0.012 | |
| axon ensheathment | GO:0008366 | 76 | 0.012 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.012 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.012 | |
| protein localization to membrane | GO:0072657 | 108 | 0.012 | |
| protein localization to vacuole | GO:0072665 | 4 | 0.012 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.012 | |
| lysosome organization | GO:0007040 | 21 | 0.012 | |
| secretion of lysosomal enzymes | GO:0033299 | 6 | 0.012 | |
| pigment granule organization | GO:0048753 | 9 | 0.012 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.012 | |
| compound eye development | GO:0048749 | 1 | 0.012 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.012 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.012 | |
| fat cell differentiation | GO:0045444 | 160 | 0.012 | |
| establishment of protein localization to vacuole | GO:0072666 | 4 | 0.012 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.012 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.012 | |
| striated muscle cell development | GO:0055002 | 125 | 0.012 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.012 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.012 | |
| vacuole organization | GO:0007033 | 38 | 0.012 | |
| organelle fission | GO:0048285 | 170 | 0.012 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.012 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.012 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.012 | |
| regulation of system process | GO:0044057 | 200 | 0.012 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.012 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.011 | |
| regulation of lamellipodium assembly | GO:0010591 | 3 | 0.011 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.011 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.011 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.011 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.011 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.011 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.011 | |
| response to acid chemical | GO:0001101 | 111 | 0.011 | |
| immune effector process | GO:0002252 | 321 | 0.011 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.011 | |
| substantia nigra development | GO:0021762 | 2 | 0.011 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.011 | |
| glucose homeostasis | GO:0042593 | 128 | 0.011 | |
| ossification | GO:0001503 | 216 | 0.011 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.011 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.011 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.011 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.011 | |
| cell growth | GO:0016049 | 130 | 0.011 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.011 | |
| ear development | GO:0043583 | 200 | 0.011 | |
| protein ubiquitination | GO:0016567 | 171 | 0.011 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.011 | |
| chromatin organization | GO:0006325 | 206 | 0.011 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.011 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.011 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.011 | |
| gtp metabolic process | GO:0046039 | 144 | 0.011 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.011 | |
| membrane fusion | GO:0061025 | 38 | 0.011 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.010 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.010 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.010 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.010 | |
| glial cell differentiation | GO:0010001 | 131 | 0.010 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.010 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.010 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.010 | |
| urogenital system development | GO:0001655 | 261 | 0.010 | |
| renal system development | GO:0072001 | 225 | 0.010 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.010 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.010 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.010 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.010 | |
| rna interference | GO:0016246 | 2 | 0.010 | |
| nuclear transport | GO:0051169 | 139 | 0.010 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.010 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.010 | |